NCT02576587View on ClinicalTrials.gov

Influence of Sleep Apnea on Risk of Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

February 22, 2017

Study Completion Date

February 22, 2017

Conditions
Sleep ApneaAtrial Fibrillation
Interventions
OTHER

Continuous Positive Airway Pressure

For cases, those found to have moderate sleep apnea (AHI \>=15) will be place on CPAP therapy.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

The Cleveland Clinic

OTHER

NCT02576587 - Influence of Sleep Apnea on Risk of Atrial Fibrillation | Biotech Hunter | Biotech Hunter